학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 403건 | 목록
1~20
Academic Journal
Theuns C; Faculty of Medicine and Health Sciences, Molecular Imaging and Radiology (MIRA), University of Antwerp, Wilrijk, Antwerp, Belgium.; Gerris A; Faculty of Medicine and Health Sciences, Molecular Imaging and Radiology (MIRA), University of Antwerp, Wilrijk, Antwerp, Belgium.; van Meerbeeck JP; Faculty of Medicine and Health Sciences, Molecular Imaging and Radiology (MIRA), University of Antwerp, Wilrijk, Antwerp, Belgium.; Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Flanders, Belgium.; Department of Radiology, Antwerp University Hospital, Edegem, Flanders, Belgium.; Van Hal G; Social Epidemiology and Health Policy, University of Antwerp, Wilrijk, Antwerp, Belgium.; Stevens F; Department of Radiology, Antwerp University Hospital, Edegem, Flanders, Belgium.; De Lepeleire J; Department of Public Health and Primary Care, KU Leuven, Leuven, Flanders, Belgium.; Primary Care Zone, South-East Region of Antwerp, Edegem, Antwerp, Belgium.; Bouziotis J; Clinical Trial Centre, CRC Antwerp, Antwerp University Hospital, Edegem, Flanders, Belgium.; Michiels L; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Leuven, Belgium.; Ramaeckers K; Flemish Association for Respiratory Healthcare and Tuberculosis Control (VRGT), Brussels, Belgium.; Snoeckx A; Faculty of Medicine and Health Sciences, Molecular Imaging and Radiology (MIRA), University of Antwerp, Wilrijk, Antwerp, Belgium.; Department of Radiology, Antwerp University Hospital, Edegem, Flanders, Belgium.
Publisher: Sage Country of Publication: England NLM ID: 9433359 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1475-5793 (Electronic) Linking ISSN: 09691413 NLM ISO Abbreviation: J Med Screen Subsets: MEDLINE
Academic Journal
Horgan, D; Baird, A-M; Middleton, M; Mihaylova, Z; Van, Meerbeeck JP; Vogel-Claussen, J; Van, Schil PE; Malvehy, J; Ascierto, PA; Dube, F
HEALTHCARE. 10(9):1618-1618
Academic Journal
Zwijsen K; Laboratorium of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp 2610 Antwerp, Belgium.; Heirwegh E; Laboratorium of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp 2610 Antwerp, Belgium.; Schillebeeckx E; Laboratorium of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp 2610 Antwerp, Belgium; VIB-UGent Center for Medical Biotechnology, 9000 Ghent, Belgium.; Marcq E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp 2610 Antwerp, Belgium; Lab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium; Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels, Belgium.; Covaci A; Toxicological Centre and Member of the Exposome Center of Excellence, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.; de Beeck KO; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp 2610 Antwerp, Belgium; Centre of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650 Edegem, Belgium.; van Meerbeeck JP; Laboratorium of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp 2610 Antwerp, Belgium; Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium.; Raskin J; Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp 2610 Antwerp, Belgium.; Janssens A; Department of Thoracic Oncology, MOCA, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp 2610 Antwerp, Belgium.; Snoeckx A; Faculty of Medicine and Health Sciences, University of Antwerp 2610 Antwerp, Belgium; Department of Radiology, Antwerp University Hospital, 2650 Edegem, Belgium.; Lamote K; Laboratorium of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp 2610 Antwerp, Belgium. Electronic address: kevin.lamote@uantwerpen.be.
Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Academic Journal
Janssens E; Laboratory of Experimental Medicine and Pediatrics, Infla-Med Center of Excellence, University of Antwerp, Antwerp 2610, Belgium.; Heirwegh E; Laboratory of Experimental Medicine and Pediatrics, Infla-Med Center of Excellence, University of Antwerp, Antwerp 2610, Belgium.; Wouters A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp 2610, Belgium.; Vandermeersch L; Department of Green Chemistry and Technology, EnVOC Research Group, Ghent University, Ghent 9000, Belgium.; Van Meerbeeck JP; Laboratory of Experimental Medicine and Pediatrics, Infla-Med Center of Excellence, University of Antwerp, Antwerp 2610, Belgium; Department of Pulmonology & Thoracic Oncology, Antwerp University Hospital, Edegem 2650, Belgium.; Walgraeve C; Department of Green Chemistry and Technology, EnVOC Research Group, Ghent University, Ghent 9000, Belgium.; Marcq E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp 2610, Belgium; Lab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium; Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels, Belgium.; Lamote K; Laboratory of Experimental Medicine and Pediatrics, Infla-Med Center of Excellence, University of Antwerp, Antwerp 2610, Belgium. Electronic address: kevin.lamote@uantwerpen.be.
Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Academic Journal
DE PAUW R; VANWALLEGHEM L; VERMASSEN F; MEERSSCHOUT S; PRAET M; DENEVE W; JOOS G; VAN MEERBEECK JP; LONG ONCOLOGISCH NETWERK GENT (LONG) UZ GENT
Tijdschrift voor Geneeskunde. :459-466
Academic Journal
In: American Journal of Respiratory & Critical Care Medicine ; (New York, New York) 7/15/2008; v.178 n.2, 209-210. (2p)
Academic Journal
Faivre-Finn, C; Snee, M; Ashcroft, L; Appel, W; Barlesi, F; Bhatnagar, A; Bezjak, A; Cardenal, F; Fournel, P; Harden, S; Le Pechoux, C; McMenemin, R; Mohammed, N; O'Brien, M; Pantarotto, J; Surmont, V; Van Meerbeeck, JP; Woll, PJ; Lorigan, P; Blackhall, F; CONVERT Study Team
Lancet Oncol
Faivre-Finn, C, Lorigan, P, Blackhall, F & The CONVERT Study Team 2017, 'Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : An open-label, phase 3, randomised, superiority trial', The Lancet Oncology, vol. 18, no. 8, pp. 1116-1125. https://doi.org/10.1016/S1470-2045(17)30318-2
LANCET ONCOLOGY
Faivre-Finn, C, Lorigan, P, Blackhall, F & The CONVERT Study Team 2017, 'Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : An open-label, phase 3, randomised, superiority trial', The Lancet Oncology, vol. 18, no. 8, pp. 1116-1125. https://doi.org/10.1016/S1470-2045(17)30318-2
LANCET ONCOLOGY
Academic Journal
Lamote K; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.; Delanghe S; Department of Nephrology, Ghent University Hospital, Ghent, Belgium.; Speeckaert MM; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Department of Nephrology, Ghent University Hospital, Ghent, Belgium; Research Foundation-Flanders (FWO), Brussels, Belgium.; van Meerbeeck JP; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Thoracic Oncology/MOCA, Antwerp University Hospital, Edegem, Belgium.; Delanghe JR; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. Electronic address: Joris.Delanghe@ugent.be.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1302422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3492 (Electronic) Linking ISSN: 00098981 NLM ISO Abbreviation: Clin Chim Acta Subsets: MEDLINE
Academic Journal
van Meerbeeck JP; Department of Thoracic Oncology, MOCA, University Hospital Antwerp, Belgium.
Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE
Academic Journal
Paternot S; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; Raspé E; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; Meiller C; Université de Paris, Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Functional Genomics of Solid Tumors, France.; Tarabichi M; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; Assié JB; Université de Paris, Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Functional Genomics of Solid Tumors, France.; CEpiA (Clinical Epidemiology and Ageing), EA 7376-IMRB, University Paris-Est Créteil, France.; GRC OncoThoParisEst, Service de Pneumologie, CHI Créteil, UPEC, Créteil, France.; Libert F; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; BRIGHTCore, ULB, Brussels, Belgium.; Remmelink M; Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, Belgium.; Bisteau X; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; Pauwels P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Blum Y; Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, Paris, France.; Le Stang N; MESOBANK, Department of Biopathology, Centre Léon Bérard, Lyon, France.; Tabone-Eglinger S; MESOBANK, Department of Biopathology, Centre Léon Bérard, Lyon, France.; Galateau-Sallé F; MESOBANK, Department of Biopathology, Centre Léon Bérard, Lyon, France.; Cancer Research Center INSERM U1052-CNRS 5286R, Lyon, France.; Blanquart C; Inserm, CNRS, Université d'Angers, CRCI2NA, Nantes Université, Nantes, France.; Van Meerbeeck JP; Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.; Berghmans T; Clinic of Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Jean D; Université de Paris, Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Functional Genomics of Solid Tumors, France.; Roger PP; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Schillebeeckx E; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Wilrijk, Belgium eline.schillebeeckx@uantwerpen.be.; Infla-Med Centre of Excellence, University of Antwerp, Wilrijk, Belgium.; van Meerbeeck JP; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Wilrijk, Belgium.; Infla-Med Centre of Excellence, University of Antwerp, Wilrijk, Belgium.; Dept of Internal Medicine, Ghent University, Ghent, Belgium.; Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.; European Reference Network for rare respiratory diseases (ERN-LUNG), Frankfurt Am Main, Germany.; Lamote K; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Wilrijk, Belgium.; Infla-Med Centre of Excellence, University of Antwerp, Wilrijk, Belgium.; Dept of Internal Medicine, Ghent University, Ghent, Belgium.
Publisher: European Respiratory Society Country of Publication: England NLM ID: 9111391 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1600-0617 (Electronic) Linking ISSN: 09059180 NLM ISO Abbreviation: Eur Respir Rev Subsets: MEDLINE
Academic Journal
Tijdschrift voor Geneeskunde. :470-477
Academic Journal
Hiddinga BI; Dept of Pulmonary Medicine and Tuberculosis, University Medical Centre Groningen, Groningen, The Netherlands b.i.hiddinga@umcg.nl.; Both authors contributed equally.; Raskin J; Dept of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.; Both authors contributed equally.; Janssens A; Dept of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.; University of Antwerp, Antwerp, Belgium.; Pauwels P; University of Antwerp, Antwerp, Belgium.; Dept of Pathology, Antwerp University Hospital, Edegem, Belgium.; European Reference Network for rare and low prevalent lung diseases (ERN-LUNG), Frankfurt am Main, Germany.; Van Meerbeeck JP; Dept of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.; University of Antwerp, Antwerp, Belgium.; European Reference Network for rare and low prevalent lung diseases (ERN-LUNG), Frankfurt am Main, Germany.
Publisher: European Respiratory Society Country of Publication: England NLM ID: 9111391 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1600-0617 (Electronic) Linking ISSN: 09059180 NLM ISO Abbreviation: Eur Respir Rev Subsets: MEDLINE
Academic Journal
Pass HI; Giroux D; Kennedy C; RUFFINI, Enrico; Cangir AK; Rice D; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP; Rusch VW; IASLC Staging Committee; Participating Institutions
J Thorac Oncol
JOURNAL OF THORACIC ONCOLOGY
JOURNAL OF THORACIC ONCOLOGY
Academic Journal
Surmont, V.; Smit, E.F.; de Jonge, M.; Aerts, JG; Nackaerts, K.; Vernhout, R.; Gras, J.; van Wijk, A.W.; Phernambucq, E.C.J.; van Meerbeeck, JP; Senan, S.; Kraaij, C.J.; Chouaki, N.; Praag, J.; van Klaveren, RJ
Surmont, V, Smit, E F, de Jonge, M, Aerts, JG, Nackaerts, K, Vernhout, R, Gras, J, van Wijk, A W, Phernambucq, E C J, van Meerbeeck , JP , Senan, S, Kraaij, C J, Chouaki, N, Praag, J & van Klaveren, RJ 2010, 'Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies', Lung Cancer, vol. 69, no. 3, pp. 302-306. https://doi.org/10.1016/j.lungcan.2009.12.001
Academic Journal
Van Schil, PE; Baas, P; Gaafar, R; Maat, A.P.W.M.; Pol, M; Hasan, B; Klomp, HM (Houke); Abdelrahman, AM; Welch, J; van Meerbeeck, JP
European Respiratory Journal. 36:1362-1369
Academic Journal
Gaafar RM; Surmont VF; SCAGLIOTTI, Giorgio Vittorio; Van Klaveren RJ; Papamichael D; Welch JJ; Hasan B; Torri V; van Meerbeeck JP; on behalf of the EORTC Lung Cancer Group; the Italian Lung Cancer Project
European Journal of Cancer. 47:2331-2340
Academic Journal
O'Brien ME; Gaafar RM; Popat S; Grossi F; Price A; Talbot DC; Cufer T; Ottensmeier C; Danson S; Pallis A; Hasan B; Van Meerbeeck JP; Baas P
European Journal of Cancer. 49:2815-2822
Academic Journal
Taylor P; Castagneto B; Dark G; Marangolo M; SCAGLIOTTI, Giorgio Vittorio; van Klaveren RJ; Labianca R; Serke M; Schuette W; van Meerbeeck JP; Heigener D; Liu Y; Adachi S; Blatter J; von Pawel J.
Journal of Thoracic Oncology. 3:764-771
검색 결과 제한하기
제한된 항목
[검색어] Van Meerbeeck, JP
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어